MedPath

The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

Not Applicable
Conditions
Pain
Interventions
Drug: Topical use
Other: laparoscopic repair of inguinal hernia
Other: laparoscopic bariatric surgery
Registration Number
NCT02826876
Lead Sponsor
Western Galilee Hospital-Nahariya
Brief Summary

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

Detailed Description

At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Laparoscopic bariatric surgery
  • Laparoscopic inguinal hernia surgery
Exclusion Criteria
  • Cardiac arrythmias
  • Active ischemic heart disease
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RopivacaineTopical useTopical use of Ropivacaine
Ropivacainelaparoscopic bariatric surgeryTopical use of Ropivacaine
PlaceboTopical useTopical use of placebo
Placebolaparoscopic repair of inguinal herniaTopical use of placebo
Placebolaparoscopic bariatric surgeryTopical use of placebo
Ropivacainelaparoscopic repair of inguinal herniaTopical use of Ropivacaine
Primary Outcome Measures
NameTimeMethod
Pain scale as measured by pain scale questionnaire1 Week

post operative pain intensity will be assisted by VAS(visual analog pain scale) scale at fixed times after surgery

Secondary Outcome Measures
NameTimeMethod
Reducing use of narcotics according to nurse records1 Week

patients will be treated by standard analgetic protocol, the records of analgetic drugs will be collected during patients hospitalization

Trial Locations

Locations (1)

Naharia Medical Center

🇮🇱

Naharia, Israel

© Copyright 2025. All Rights Reserved by MedPath